CPHI 2010
InicioMapa del sitioKyowa Hakko EuropeInnovaciónProductosNoticias & mediosContactoKyowa Hakko Worldwide
Results of phase-III clinical studies of an anti-Parkinson’s disease drug conducted overseas
07 March 2006

Results of phase-III clinical studies of an anti-Parkinson's disease drug Istradefylline/KW-6002 conducted overseas

Kyowa Hakko Kogyo Co., Ltd. located in Chiyoda-ku, Tokyo, Japan (President: Dr. Yuzuru Matsuda) has completed three Phase III clinical studies of KW-...
Leer más»
Kyowa Hakko in-licenses a self-injectable product to treat Parkinson’s disease
07 February 2006

Kyowa Hakko in-licenses a self-injectable product to treat Parkinson’s disease from Britannia Pharmaceuticals Limited in the U.K.

On February 7, 2006, Kyowa Hakko Kogyo Co., Ltd. based in Tokyo, Japan (President and CEO: Dr. Yuzuru Matsuda) entered into a license ...
Leer más»
Kyowa Hakko Reports Good Progress Towards Full-year Forecasts
30 January 2006

Tokyo, January 30, 2006 --- Kyowa Hakko Kogyo Co., Ltd. (Kyowa Hakko) today announced its third quarter results for the nine-month period from April 1, 2005 to December 31, 2005. Consolidated net sales and operating income declined compared to the first nine m...
Leer más»
Kyowa Hakko’s mitotic kinesin Eg5 inhibitor
10 January 2006

Kyowa Hakko's mitotic kinesin Eg5 inhibitor, a candidate anticancer agent developed in-house, is licensed to Eli Lilly and Company in the US

On December 19th, 2005, Kyowa Hakko Kogyo Co., Ltd. (Kyowa Hakko) based ...
Leer más»
Kyowa Hakko Interim Profits Ahead of Forecast, Full-year Forecasts Reaffirmed
31 October 2005

Tokyo, October 31, 2005 --- Kyowa Hakko Kogyo Co., Ltd. (Kyowa Hakko) today announced its consolidated financial results for the interim period of fiscal 2005 (the six-month period ended September 30, 2005). Operating income, recurring income and net income ea...
Leer más»
Increase in 2-ETHYLHEXANOIC ACID production
06 September 2005

Increase in 2-ETHYLHEXANOIC ACID production positions KYOWA HAKKO as world leader in fatty acid manufacturing

TOKYO, Japan - Kyowa Hakko Chemical Co., Ltd. announced that it will increase production of 2-Ethylhexanoic Acid at the company's Yokkaichi pla...
Leer más»
New Manufacturing Technology for Amino Acid Dimers (di-peptides)
21 September 2004

A Significant Playin the Growing High Value-added Amino Acid Industry

TOKYO, Japan, Sep 21, 2004 Kyowa Hakko Kogyo Co., Ltd. (Kyowa Hakko), one of Japan's leading companies in the pharmaceutical and biotechnology in...
Leer más»

Displaying results 29 to 35 out of 36

< Anterior

1

2

3

4

5

6

Siguiente >